White Paper RWE needs in Oncology: Prostate Cancer
REAL WORLD EVIDENCE NEEDS IN ONCOLOGY: Prostate Cancer White Paper based on new trial results from ESMO Congress, 20-24 October 2023, Madrid. As the second most common cancer in men worldwide, prostate cancer poses substantial healthcare burdens and necessitates continuous research and innovation in treatment strategies. OXON has analyzed the results of the trials presented…
Read more